📄 Direct examination of Collin Yamauchi (part 1) — Wednesday, May 24, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\24\DIRECT-EXAMINATION-OF-COLLIN-Y.DOC
TRIAL
▲ Day 81 of 167

Direct examination of Collin Yamauchi (part 1)

Witness: Collin Yamauchi
Examiner: Rockne Harmon
Called by: Prosecution • Date: Wednesday, May 24, 1995 • Utterances: 380
The morning session of Collin Yamauchi's direct examination covers his background, education, and qualifications as an LAPD criminalist specializing in PCR DQ-Alpha DNA typing. Harmon walks the jury through Yamauchi's five years in the LAPD serology unit, his training history, and proficiency testing record before pivoting to June 13-14, 1994, where Yamauchi describes being tapped by supervisor Greg Matheson to work the Simpson case and subsequently meeting with Dennis Fung to select evidence for analysis.
1 MR. HARMON:

Thank you, your Honor. Ladies and gentlemen.

DIRECT EXAMINATION BY MR. HARMON

2 MR. HARMON:

Mr. Yamauchi, who do you work for now?

3 MR. YAMAUCHI:

The Los Angeles Police Department.

4 MR. HARMON:

In what capacity?

5 MR. YAMAUCHI:

I'm a criminalist.

6 MR. HARMON:

How long have you worked for the Los Angeles Police Department as a criminalist?

7 MR. YAMAUCHI:

For five years now.

8 MR. HARMON:

Okay. What are your present duties?

9 MR. YAMAUCHI:

I'm assigned to the serology unit.

10 MR. HARMON:

Could you describe what that entails?

11 MR. YAMAUCHI:

Serology is the unit that specializes in body fluids, most commonly blood and those found in sexual assaults.

12 MR. HARMON:

How long have you been assigned to the serology unit?

13 MR. YAMAUCHI:

I've been the whole time that I have been at LAPD in the serology unit.

14 MR. HARMON:

For five years? Do you presently perform a form of DNA typing on forensic samples?

15 MR. YAMAUCHI:

Yes.

16 MR. HARMON:

What kind of test do you perform?

17 MR. YAMAUCHI:

The PCR DQ-Alpha.

18 MR. HARMON:

And prior to using PCR DQ-Alpha did you also perform other forms of serological testing?

19 MR. YAMAUCHI:

Yes, I did. I did conventional serology.

20 MR. HARMON:

And do you do that to this date as well as the PCR DQ-Alpha?

21 MR. YAMAUCHI:

You mean simultaneously?

22 MR. HARMON:

Who, not simultaneously. Are you also performing conventional serology on evidence to this date?

23 MR. YAMAUCHI:

Well, once in a while, yes.

24 MR. HARMON:

Let's go back, if you will, to your undergraduate education. Do you have an undergraduate degree?

25 MR. YAMAUCHI:

Yes, I do.

26 MR. HARMON:

Where did you obtain that?

27 MR. YAMAUCHI:

From the California State University Long Beach.

28 MR. HARMON:

What year?

29 MR. YAMAUCHI:

I graduated in `86.

30 MR. HARMON:

Okay. And could you describe your major?

31 MR. YAMAUCHI:

My major is in biology.

32 MR. HARMON:

And let's talk about your undergraduate education for a bit. Okay? And specifically I would like to briefly discuss or describe the kind of courses that you took to obtain the degree in biology that relate in some way to the forensic DNA typing and conventional serology that you perform on evidence samples. Would you do that?

33 MR. YAMAUCHI:

Umm, oh, just list off courses that I have taken?

34 MR. HARMON:

Sure.

35 MR. YAMAUCHI:

Pertinent to--okay. Cellular biology, that would deal with molecular components of the cell, and talk about the genetics also. I have also taken genetics, and there is a number of battery of courses that--well, right now offhand I can't remember them all.

36 MR. HARMON:

Okay. After you graduated from college, what did you do?

37 MR. YAMAUCHI:

I worked three and a half years at ICN Radiochemicals.

38 MR. HARMON:

What sorts of jobs did you perform there?

39 MR. YAMAUCHI:

I was a quality control chemist.

40 MR. HARMON:

Can you describe what that entails?

41 MR. YAMAUCHI:

By--that entails analyzing chemicals for Radiochemicals and chemical purity. These chemicals are often used in, for example, DNA research. There would be the radioactive probes, the components of that, that people use in even like RFLP research and things like that.

42 MR. HARMON:

And what sorts of actual--can you describe the actual hands-on work that you did when you were working there?

43 MR. YAMAUCHI:

Well, it is technical, but I can name names. Some of the things I did was nick translation and random primer labeling--

44 MR. HARMON:

I'm sorry--

45 MR. YAMAUCHI:

--as well--

46 MR. HARMON:

--did you finish?

47 MR. YAMAUCHI:

Well, no. That is fine.

48 MR. HARMON:

Do you wear gloves?

49 MR. YAMAUCHI:

Well, when you are working with radiation it is very important to wear gloves and you have to wear gloves and change them constantly.

50 MR. HARMON:

Wear a lab coat?

51 MR. YAMAUCHI:

Yes.

52 MR. HARMON:

Have to be careful about what you touched?

53 MR. YAMAUCHI:

Definitely.

54 MR. HARMON:

At some point when you worked at ICN did you take some molecular classes at Bethesda research laboratories?

55 MR. YAMAUCHI:

Yes, I did.

56 MR. HARMON:

Could you describe those classes, please?

57 MR. YAMAUCHI:

Back then I took a class, it had to do with molecular cleaning, which was kind of a process that is used to make more DNA that they were more used to using back in the past before PCR really got its start.

58 MR. HARMON:

Did you have to wear gloves with that?

59 MR. YAMAUCHI:

Yes.

60 MR. HARMON:

And be careful?

61 MR. YAMAUCHI:

Of course.

62 MR. HARMON:

What did you have to be careful about when you were doing those sorts of jobs or assignments?

63 MR. YAMAUCHI:

Well, in a different way, when working with radios, you don't want to contamination yourself, obviously, but you can also cross-contaminate the different types of chemicals that you are working with, so to a certain extent both names are very important as far as wearing gloves and keeping good solid practices and procedures.

64 MR. HARMON:

Okay. You mentioned the term cross-contamination. You know we are going to be talking about that quite a bit, so that is something that is not unique to the forensic application of DNA typing?

65 MR. YAMAUCHI:

No, it is not.

66 MR. HARMON:

That is a standard laboratory practice in your career before you joined the police department?

67 MR. YAMAUCHI:

As far as wearing gloves and changing them, yes.

68 MR. HARMON:

And being careful?

69 MR. YAMAUCHI:

Yes.

70 MR. HARMON:

Okay. When did you actually join the Los Angeles Police Department, do you recall the month and the year?

71 MR. YAMAUCHI:

And I believe 1990.

72 MR. HARMON:

Okay. And after you joined the police department did you continue to take courses in your area of interest?

73 MR. YAMAUCHI:

Yes, I did.

74 MR. HARMON:

Both through the police department and elsewhere?

75 MR. YAMAUCHI:

Well, they were all through the police department or through the lab, yeah.

76 MR. HARMON:

Okay. Why don't you describe some of them.

77 MR. YAMAUCHI:

Umm, well, could I refer to my CV?

78 MR. HARMON:

Sure. While you are looking that up, you are not a peace officer; is that right?

79 MR. YAMAUCHI:

No, I'm a civilian.

80 MR. HARMON:

Okay.

81 (Brief pause.)
82 THE COURT:

Mr. Scheck, do you have a copy of the CV?

83 MR. SCHECK:

Perhaps not the latest version.

84 THE COURT:

Mr. Scheck, do you want to just take a look at what Mr. Yamauchi has.

85 MR. SCHECK:

Yes. Thank you very much.

86 (Brief pause.)
87 THE COURT:

All right. Mr. Harmon.

88 MR. HARMON:

Thank you, your Honor.

89 MR. HARMON:

Could you, from the earliest to the most recent, could you describe the kind of courses which lend themselves to the expertise that you have in the area of forensic DNA typing as well as conventional serology?

90 MR. SCHECK:

Objection. Assumes a fact not in evidence yet.

91 THE COURT:

Overruled.

92 MR. YAMAUCHI:

Okay. I started out, umm, taking a forensic serology class in May of 1990 and that was at the California Criminalistics Institute in Sacramento, California. That is a part of the Department of Justice. And, umm, in July of 1991 I had a zone electrophoresis class also at the California Criminalistics Institute up at the DOJ. I have--I have been to a crime scene investigation class also through the California Criminalistics Institute and I have received training at a place called AGTC in Denver, Colorado, for immunoglobulin allotyping training.

93 MR. HARMON:

Could you describe what that is, just briefly?

94 MR. YAMAUCHI:

That--that is--that is kind of a fancy name for something that is very similar to the ABO system, except it gives you more information.

95 MR. HARMON:

An AGTC, is that a private laboratory that regularly conducts training sessions?

96 MR. YAMAUCHI:

Yes. As far as I know, yes.

97 MR. HARMON:

Okay. Go ahead. I didn't mean to interrupt you.

98 MR. YAMAUCHI:

And in September of `91 to January of `92 I took a class through I believe it was Cal State Fullerton and it was held at the Orange County Sheriff's crime laboratory and that dealt with the forensic application of molecular biology.

99 MR. HARMON:

Okay. Now, is that the first forensic class that you took with respect to DNA typing?

100 MR. YAMAUCHI:

Forensic? Yes--yeah, I believe so.

101 MR. HARMON:

And the Orange County crime lab has their own DNA lab; is that correct?

102 MR. YAMAUCHI:

Yes, they do.

103 MR. HARMON:

Are those the people that conducted the class?

104 MR. YAMAUCHI:

No. This was held by a professor from California State Fullerton.

105 MR. HARMON:

Okay. Do you recall whose name--what his name was?

106 MR. YAMAUCHI:

I believe Frommson.

107 MR. HARMON:

Okay. Why don't you take up from there then, the next classes that you took.

108 MR. YAMAUCHI:

In--well, actually in January of `92 I had an isoelectric focusing class also at the California Criminalistics Institute, and in August of `93 I went to forensic PCR amplification training workshop and that is put on by Roche molecular systems who had the patent and they still do have the patent on PCR.

109 MR. HARMON:

Are they the ones that have developed, manufactured and produced the kits that are used for PCR DQ-Alpha typing?

110 MR. YAMAUCHI:

Yes.

111 MR. HARMON:

Where was that course conducted?

112 MR. YAMAUCHI:

Umm, that was at Alameda, California, at that time.

113 MR. HARMON:

Okay. How many hours did that class or did that class consist of?

114 MR. YAMAUCHI:

About 64.

115 MR. HARMON:

And did you get any sort of credits for that?

116 MR. YAMAUCHI:

There was a certification of completion, yes.

117 MR. HARMON:

So you got some sort of certificate?

118 MR. YAMAUCHI:

Yes.

119 MR. HARMON:

Did that entail hands-on work?

120 MR. YAMAUCHI:

Yes, it did.

121 MR. HARMON:

Can you describe that, please?

122 MR. YAMAUCHI:

Well, we went through the PCR process with DQ-Alpha, as well as other markers which I--I don't do yet, but we are working on getting that on line, and that would be D1S80, which was discussed earlier, and also the polymarker system.

123 MR. HARMON:

Who are the instructors in that course?

124 MR. YAMAUCHI:

Well, we had Henry Erlich talked for a while, we had Jennifer Mihalovich from Ed Blake's lab came and talked, Judy Allen I believe is her name was the coordinator of the class. And let's see. Brian Wraxall I believe was there to talk for a little while at the end also.

125 MR. HARMON:

Okay. How many students were in the group?

126 MR. YAMAUCHI:

Somewhere between 15 and 20.

127 MR. HARMON:

And were these people from all over the country?

128 MR. YAMAUCHI:

Yes.

129 MR. HARMON:

Did you have to take any sort of exam? You mentioned you got a certificate. Was there an exam involved, too?

130 MR. YAMAUCHI:

I believe there was.

131 MR. HARMON:

Okay. Do you continue to keep abreast of developments in forensic DNA typing as well as forensic--forensic serology?

132 MR. YAMAUCHI:

Yes. I'm a member of the California association of criminalists, and one of the things that they have associated with that are monthly study group meetings and I try to attend those as much as possible.

133 MR. HARMON:

Okay. Do you also read scientific literature in the areas that you are interested in?

134 MR. YAMAUCHI:

As far as pertaining to the case work I do.

135 MR. HARMON:

Sure.

136 MR. YAMAUCHI:

Of course, yeah.

137 MR. HARMON:

What journals do you read?

138 MR. YAMAUCHI:

Well, there is a number of them. Just--specifically?

139 MR. HARMON:

Sure.

140 MR. YAMAUCHI:

Well, I have read articles pertaining directly to the PCR process. I can't remember all the names and the titles and the abstracts and that.

141 MR. HARMON:

When did you first become exposed to PCR DQ-Alpha typing at the Los Angeles Police Department lab?

142 MR. YAMAUCHI:

First become exposed?

143 MR. HARMON:

Yes.

144 MR. YAMAUCHI:

Could you clarify that?

145 MR. HARMON:

When did you first become aware that the--that the laboratory was going to do PCR DQ-Alpha typing?

146 MR. YAMAUCHI:

Well, from the day I started there was talk as to implementation of the DNA technologies and at first they were talking about RFLP and that was what was of interest. And later on, as the PCR technology developed and it seemed more feasible, that was talked about more and more.

147 MR. HARMON:

And that is about the same time you started taking the classes that had to do with PCR typing?

148 MR. YAMAUCHI:

I believe they were talking about it before that.

149 MR. HARMON:

Okay. How did it come about that that became part of your assignment, PCR typing?

150 MR. YAMAUCHI:

Well, I believe I--because of my background working at ICN I had some experience working with DNA.

151 MR. HARMON:

And when did that happen, the decision to have you do some PCR typing?

152 MR. YAMAUCHI:

To learn and be trained? It must have been sometime in 1993.

153 MR. HARMON:

Okay. When did you first begin using just in-house PCR DQ-Alpha typing?

154 MR. YAMAUCHI:

When did I do the--my first case or--

155 MR. HARMON:

When did you just begin your handling of PCR DQ-Alpha typing at LAPD in any form?

156 MR. YAMAUCHI:

I'm sorry, I don't have the specific date to that, but it would have been in 1993 sometime.

157 MR. HARMON:

Early or late `93?

158 MR. YAMAUCHI:

Probably mid.

159 MR. HARMON:

Okay. And were you the first person in the laboratory to begin implementing PCR DQ-Alpha typing?

160 MR. YAMAUCHI:

No.

161 MR. HARMON:

Who was?

162 MR. YAMAUCHI:

Erin Riley.

163 MR. HARMON:

And when did that begin?

164 MR. YAMAUCHI:

I'm not specifically sure.

165 MR. HARMON:

How long before you began implementing PCR was it that she had begun?

166 MR. YAMAUCHI:

Well, we were assigned the project together, except she was given more of the responsibilities because she had training from the FBI, and I'm not real sure when that was, but it was prior to `93.

167 MR. HARMON:

Now, what--will you describe who Erin Riley is and what her specific assignment and title is within the laboratory?

168 MR. YAMAUCHI:

I'm sorry. She is also another criminalist last working in the serology unit. We work together. She is also a criminalist 2.

169 MR. HARMON:

Okay. Had the LAPD laboratory, not you, but the laboratory itself, begun accepting case work before you began accepting cases?

170 MR. YAMAUCHI:

Case work as to the PCR process?

171 MR. HARMON:

Yes.

172 MR. YAMAUCHI:

Well, yes, we did in a way. We did accept cases and, umm, after conventional screening they may or may not have been shipped off to different laboratories that did have the technology on line.

173 MR. HARMON:

Okay. And what was--will you describe your first exposure to PCR typing in the laboratory. I'm not talking about case work, I mean the first actual case work you had within the laboratory, aside from the classes just describe for the jury.

174 MR. SCHECK:

Object to the term "Exposure" as vague.

175 THE COURT:

Sustained. Do you want to rephrase that, please.

176 MR. HARMON:

When did you first begin performing PCR DQ-Alpha analysis, not in case work, just in any form within the laboratory?

177 MR. YAMAUCHI:

PCR--once again, that would have been sometime in 1993. I don't have the specific date.

178 MR. HARMON:

Okay. What did you do prior to that with respect to PCR DQ-Alpha typing before you actually began performing tests?

179 MR. YAMAUCHI:

I did conventional serology.

180 MR. HARMON:

Okay. But with regard to PCR DQ-Alpha, what--did you just pick it up one day and start doing it?

181 MR. YAMAUCHI:

Did I--I'm sorry, I don't--

182 MR. HARMON:

Did you study protocols before you began performing the tests?

183 MR. YAMAUCHI:

Yes, of course.

184 MR. HARMON:

Okay. Would you tell us how you began your implementation period with PCR DQ-Alpha.

185 MR. YAMAUCHI:

Well, I went over the user guide that is provided by Roche molecular systems and looked through that and this would have been prior to--to my even going to the class. But Erin Riley had been to the class, and so I had that information available to me, and I went over those protocols and procedures and with Ms. Riley's help I went through and tried to run the strips.

186 MR. HARMON:

Okay. And over how long a period did this implementation last for you before you began doing case work?

187 MR. YAMAUCHI:

Between the parts where I was studying and everything? Six to eight months.

188 MR. HARMON:

And was it in that period that you took any of these classes as well?

189 MR. YAMAUCHI:

Yes.

190 MR. HARMON:

And which of the classes, the one at Roche?

191 MR. YAMAUCHI:

Yes.

192 MR. HARMON:

Okay. Before you--do you remember when you actually began or accepted your first case for PCR DQ-Alpha typing?

193 MR. YAMAUCHI:

I believe I have it written somewhere.

194 MR. HARMON:

Sure, if it would help to refresh your recollection if you've got it written down somewhere.

195 MR. YAMAUCHI:

The first case was assigned to me in October of `93 and the first case for PCR that I completed was in November of `93.

196 MR. SCHECK:

Your Honor, may I just look at the note that he is looking at?

197 THE COURT:

Yes.

198 (Brief pause.)
199 THE COURT:

Mr. Harmon.

200 MR. HARMON:

Thank you, your Honor.

201 MR. HARMON:

The jury has seen some of these strips, okay, and what I want to do is I want you to describe about how many strips or tests that you actually performed using the PCR DQ-Alpha system before you accepted your first case? Do you have any idea?

202 MR. YAMAUCHI:

How many strips? Well over a hundred. I would have to go back and count, though.

KEY QUOTE
203 MR. HARMON:

You could, if you had to?

204 MR. YAMAUCHI:

Yes.

205 MR. HARMON:

Go back and count? In terms of conventional serology electrophoresis tests, can you give the jury some sense of how many times you performed those sorts of tests on evidence samples?

206 MR. YAMAUCHI:

Electrophoresis? Hundreds of times.

207 MR. HARMON:

Okay. Have you ever testified as an expert in the field of conventional serology, electrophoretic typing?

208 MR. YAMAUCHI:

Yes.

209 MR. HARMON:

How many times?

210 MR. YAMAUCHI:

Oh, over twenty.

211 MR. HARMON:

Over how long a period of time?

212 MR. YAMAUCHI:

The five years I have been a criminalist.

213 MR. HARMON:

Do you take any sort of proficiency tests?

214 MR. YAMAUCHI:

Yes. We are--we run samples from CTS and College of American Pathologists.

215 MR. HARMON:

Okay. Now, that is for the PCR DQ-Alpha system?

216 MR. YAMAUCHI:

Yes, and they have--they also have for conventional serology.

217 MR. HARMON:

And have you taken any--I'm sorry. Have you taken conventional serology proficiency tests?

218 MR. YAMAUCHI:

I have once.

219 MR. HARMON:

Okay. How many times have you taken proficiency--

220 MR. SCHECK:

Objection. 1054 objection as to the conventional serology tests.

221 THE COURT:

Overruled.

222 MR. HARMON:

How many proficiency tests have you taken which depend on the PCR DQ-Alpha marker?

223 MR. YAMAUCHI:

I would say approximately eight or nine.

224 MR. HARMON:

Over how long a period of time?

225 MR. YAMAUCHI:

Well, the year and a half or so that I have been doing PCR.

226 MR. HARMON:

And did you actually take any proficiency tests before you accepted your first case work in October of `93?

227 MR. YAMAUCHI:

I might have. I would have to go back and check the records.

228 MR. HARMON:

Now, you mentioned two organizations. CTS--

229 MR. YAMAUCHI:

Yes.

230 MR. HARMON:

--is that the collaborative testing service?

231 MR. YAMAUCHI:

Yes, it is.

232 MR. HARMON:

And when you take those tests, do you know it is a proficiency test?

233 MR. YAMAUCHI:

Yes.

234 MR. HARMON:

Do you know what the answer is ahead of time?

235 MR. YAMAUCHI:

No, I don't.

236 MR. HARMON:

When you take the CAP, that is the College of American Pathologists?

237 MR. YAMAUCHI:

Yes.

238 MR. HARMON:

Okay. Do you know the answer ahead of time when you take that test?

239 MR. YAMAUCHI:

No.

240 MR. HARMON:

Do you know it is a proficiency test?

241 MR. YAMAUCHI:

Yes, I do.

242 MR. HARMON:

Okay. Have you ever been graded as having made a mistake in any of those proficiency tests?

243 MR. YAMAUCHI:

No.

244 MR. HARMON:

Does that mean you couldn't make a mistake?

245 MR. YAMAUCHI:

Does that--well, no, it doesn't.

246 MR. HARMON:

Have you ever testified as an expert in a court in the field of forensic PCR DQ-Alpha typing?

247 MR. YAMAUCHI:

Yes.

248 MR. HARMON:

How many times?

249 MR. YAMAUCHI:

Twice.

250 MR. HARMON:

In what courts? In this county?

251 MR. YAMAUCHI:

Yes.

252 MR. HARMON:

Have there been times--have there ever been times when you have attempted to testify but have not been found qualified to testify in the field of PCR DQ-Alpha typing?

253 MR. YAMAUCHI:

No.

254 MR. HARMON:

When were those two times?

255 MR. YAMAUCHI:

I would have to go back and check the records.

256 MR. HARMON:

Okay. Can you give us a ballpark?

257 MR. YAMAUCHI:

Last year.

258 MR. HARMON:

Now, in the tests that you performed, the PCR DQ-Alpha testing, have you ever excluded anyone who was suspected of having committed a crime?

259 MR. YAMAUCHI:

Yes.

260 MR. HARMON:

Any idea how many times?

261 MR. YAMAUCHI:

Well, offhand I can think of at least once, but there might have been more.

262 MR. HARMON:

How many strip test samples have you subjected to the PCR DQ-Alpha test as you sit there today?

263 MR. YAMAUCHI:

I'm not sure. I would have to go back and count them all.

264 MR. HARMON:

Can you give us a ballpark figure?

265 MR. YAMAUCHI:

Well, 500, a thousand, maybe even more than that. I don't know.

266 MR. HARMON:

Do you have any idea how many actual cases you have worked on for PCR DQ-Alpha typing?

267 MR. YAMAUCHI:

I believe around sixty.

268 MR. HARMON:

Does the Los Angeles Police Department have a lengthy written protocol for the performance of PCR DQ-Alpha testing?

269 MR. SCHECK:

Objection, characterization.

270 THE COURT:

Sustained. Rephrase the question.

271 MR. HARMON:

Does the Los Angeles Police Department scientific investigations have a written PCR protocol?

272 MR. YAMAUCHI:

Yes. We have a set of guidelines for PCR practices.

273 MR. HARMON:

Okay. And does the protocol include other PCR markers in addition to DQ-Alpha?

274 MR. YAMAUCHI:

I believe so at this time.

275 MR. HARMON:

Okay. And are you familiar with the Los Angeles Police Department scientific investigation written protocol?

276 MR. YAMAUCHI:

Yes, I'm familiar with it.

277 MR. HARMON:

Is it based on the Roche DQ-Alpha user guide?

278 MR. YAMAUCHI:

Yeah, many parts of it are very similar.

279 MR. HARMON:

We are going to talk about some events in June and then move on pretty shortly, but I'm going to ask you questions about PCR DQ-Alpha tests you performed on evidence in this case in the middle of June, okay? But before we get to that, I would like to ask you generally, when you performed the tests that you will be testifying about shortly on the evidence samples in this case, did you perform them in accordance with the Los Angeles Police Department SID written protocol for PCR DQ-Alpha typing?

280 MR. SCHECK:

Objection, assumes fact not in evidence.

281 THE COURT:

Overruled.

282 MR. YAMAUCHI:

Yes, I did.

283 MR. HARMON:

Let's go back to June 13, 1994. What hours were you working those days?

284 MR. YAMAUCHI:

It was either 7:00 to 3:30 or 7:30 to 4:00.

285 MR. HARMON:

Okay. Do you recall late in your workday on June 13th having a conversation with Greg Matheson about what you know this case is about?

286 MR. YAMAUCHI:

Yes.

287 MR. HARMON:

And what did Mr. Matheson discuss with you?

288 MR. YAMAUCHI:

He asked me if I--

289 MR. SCHECK:

Objection, hearsay.

290 THE COURT:

Sustained.

291 MR. HARMON:

It is not offered for the truth of the matter, your Honor.

292 THE COURT:

Sustained.

293 MR. HARMON:

Did you have a discussion with Mr. Matheson about this case?

294 MR. YAMAUCHI:

Yes, I did.

295 MR. HARMON:

And based on this case--and did you consider what Mr. Matheson discussed with you late on June 13th in deciding what tests to perform ultimately in this case?

296 MR. YAMAUCHI:

Yes.

297 MR. HARMON:

Did you actually do anything with respect to this case on June 13th?

298 MR. YAMAUCHI:

No, I did not.

299 MR. HARMON:

Other than the conversation with Mr. Matheson?

300 MR. YAMAUCHI:

Yes, other than that conversation.

301 MR. HARMON:

Do you remember what time you came to work on June 14th?

302 MR. YAMAUCHI:

June 14th?

303 MR. HARMON:

Yes.

304 MR. YAMAUCHI:

Oh, 7:00 or 7:30.

305 MR. HARMON:

Okay. And did you have another discussion with Mr. Matheson?

306 MR. YAMAUCHI:

I believe I talked to him in the morning, yes.

307 MR. HARMON:

Now, were--you are in the serology division, okay. Do you have a separate room within the laboratory?

308 MR. YAMAUCHI:

Serology?

309 MR. HARMON:

Yes.

310 MR. YAMAUCHI:

Yes. There is a serology unit area.

311 MR. HARMON:

Okay. And is that something that there is security to get in, some sort of security device?

312 MR. YAMAUCHI:

We have to use our access cards.

313 MR. HARMON:

And do you understand there is actually a printout that shows the comings and goings of people if they use the access card?

314 MR. YAMAUCHI:

Yes.

315 MR. HARMON:

Have you seen those things occasionally, the printout?

316 MR. YAMAUCHI:

Yes, I have.

317 MR. HARMON:

Where was Mr. Matheson's office at that time with respect to serology?

318 MR. YAMAUCHI:

At the time he was serology supervisor. His office would be within the serology unit.

319 MR. HARMON:

Did you talk about this case?

320 MR. YAMAUCHI:

Yes.

321 MR. HARMON:

What did you discuss with Mr. Matheson?

322 (No audible response.)
323 MR. SCHECK:

At this point a hearsay objection.

324 THE COURT:

Sustained.

325 MR. HARMON:

It is to explain future conduct. It is not offered for the truth of the matter, your Honor.

326 MR. SCHECK:

Maybe if I could get an idea of what he intends--

327 THE COURT:

Why don't you confer with counsel.

328 MR. SCHECK:

I'm sorry?

329 THE COURT:

Why don't you confer with counsel.

330 (Discussion held off the record between Deputy District Attorney and Defense counsel.)
331 MR. SCHECK:

One second.

332 THE COURT:

All right.

333 (Discussion held off the record between Defense counsel.)
334 MR. SCHECK:

No problem.

335 THE COURT:

Withdraw your objection?

336 MR. SCHECK:

Based on what he told me.

337 THE COURT:

Proceed.

338 MR. HARMON:

I'm going to turn the clock back a day then and ask you let's go back to June 13th, the end of the day. You have a discussion with Mr. Matheson about the case?

339 MR. YAMAUCHI:

Yes.

340 MR. HARMON:

What did Mr. Matheson tell you at that time about the case?

341 MR. YAMAUCHI:

He asked me if I would want to work on this case. He is not sure of all the aspects, but he believes that it could involve sexual assault, as well as blood evidence and conventional and quite possibly PCR testing.

KEY QUOTE
342 MR. HARMON:

Okay. What else came--anything else come up in that conversation?

343 MR. YAMAUCHI:

I can't remember back all that well.

344 MR. HARMON:

Okay. Let's talk about the next morning. You go in and you are talking to Mr. Matheson again. Did you have a more specific discussion with him at that point?

345 MR. YAMAUCHI:

Yes, I believe so. He probably had more information then, so we would talk more.

346 MR. HARMON:

And could you tell us what you and Mr. Matheson discussed at that point?

347 MR. YAMAUCHI:

At that point he--he seemed to think that we--we had evidence that would need certain types of specific testing, and I recall him talking possibly doing something that would be fast, like an ABO test, and we discussed that a little bit. And I said, well, ABO has, umm, limited power of separating things out, because, for instance, a type o can be approximately half of the population, and so because that system is kind of weak in that respect, we discussed the possibility of using PCR DQ-Alpha, because that would have a little bit better chance of sorting things out into finer groups.

348 MR. HARMON:

And you mentioned that speed was somehow of importance. Why was that?

349 MR. YAMAUCHI:

I believe at the time there were reasons that I wasn't quite aware of or made aware of, but they had to do with the investigative reasons why the detectives would need results rather quickly.

KEY QUOTE
350 MR. HARMON:

During the discussion with Mr. Matheson were specific items of evidence talked about?

351 MR. YAMAUCHI:

He referred me to Dennis Fung to discuss what items of evidence would be good to pick and choose for analysis.

352 MR. HARMON:

Was anyone else there in serology at the time you had this conversation with Greg Matheson?

353 MR. YAMAUCHI:

Well, I can't remember back all that well who was there and who wasn't.

354 MR. HARMON:

Is that an area where many people work?

355 MR. YAMAUCHI:

Yeah, there is. Usually the serology unit members are always in and out.

356 MR. HARMON:

And did you have this conversation with Mr. Matheson in his office or out in the laboratory work area?

357 MR. YAMAUCHI:

One or the other.

358 MR. HARMON:

Okay. As a result of that conversation--strike that. Was Dennis Fung a party to this conversation?

359 MR. YAMAUCHI:

I believe I first talked to Dennis back in the evidence processing room.

360 MR. HARMON:

Before or after this conversation?

361 MR. YAMAUCHI:

It would be afterwards.

362 MR. HARMON:

So was Dennis Fung present while you were having this conversation with Greg Matheson?

363 MR. YAMAUCHI:

I'm not sure.

364 MR. HARMON:

After the discussion that you have just mentioned to us, did you go back to find Dennis?

365 MR. YAMAUCHI:

Yes. I--that would--that would have been the next thing on my mind, to look for Dennis to go discuss what stains to pick out and analyze.

366 MR. HARMON:

Is that what you did?

367 MR. YAMAUCHI:

Yes.

368 MR. HARMON:

Where did you find him?

369 MR. YAMAUCHI:

I believe I must have--well, let's see here. Yeah, I would have talked to him in the evidence processing room, because that is where he would be discussing the evidence with me.

370 MR. HARMON:

And do you recall about how long after the conversation with Greg Matheson it was that you found Dennis Fung and talked to him about the case in the evidence processing room?

371 MR. YAMAUCHI:

It has got to be less than half an hour, fifteen minutes--less than fifteen minutes.

372 MR. HARMON:

Okay. Do you recall if anyone else was present when you had a conversation that you will be telling us about this afternoon with Dennis Fung?

373 MR. YAMAUCHI:

This afternoon? What was that?

374 MR. HARMON:

Sorry. It was a bad question. Can we take the break now, your Honor, before we move on?

375 THE COURT:

Yes. Why don't you ask him that last question.

376 MR. HARMON:

Sure.

377 MR. HARMON:

Was anyone else present when you had the conversation with Dennis Fung about this case?

378 MR. YAMAUCHI:

No.

379 MR. HARMON:

Okay.

380 THE COURT:

All right. Ladies and gentlemen, we are going to take to our recess for the morning session. Please remember all of my admonitions to you. Don't discuss this case amongst yourselves, don't form any opinions about the case, don't conduct any deliberations until the matter has been submitted to you, do not allow anybody to communicate with you with regard to the case. Counsel, we will stand in recess until one o'clock. And let me see Miss Clark and Mr. Cochran.

Temperature

procedural

Key Quotes (4)

Collin Yamauchi
He asked me if I would want to work on this case. He is not sure of all the aspects, but he believes that it could involve sexual assault, as well as blood evidence and conventional and quite possibly PCR testing.
Yamauchi recounts Matheson's initial briefing on June 13th, revealing that a sexual assault angle was initially considered before the case scope became clear.
Collin Yamauchi
ABO has, umm, limited power of separating things out, because, for instance, a type o can be approximately half of the population, and so because that system is kind of weak in that respect, we discussed the possibility of using PCR DQ-Alpha, because that would have a little bit better chance of sorting things out into finer groups.
Establishes Yamauchi's scientific rationale for choosing PCR over conventional ABO typing — directly relevant to the defense's later challenges to DNA methodology.
Collin Yamauchi
I believe at the time there were reasons that I wasn't quite aware of or made aware of, but they had to do with the investigative reasons why the detectives would need results rather quickly.
Yamauchi admits he was kept partially in the dark about why speed mattered, hinting at investigative pressure on the lab from early in the case.
Collin Yamauchi
Well over a hundred. I would have to go back and count, though.
Responding to how many PCR strips he ran before his first case — Harmon is building a foundation of competence to preempt defense attacks on Yamauchi's experience level.

Evidence (4)

Informal
LAPD SID written protocol for PCR DQ-Alpha typing
discussed; Yamauchi confirms he followed it
Informal
Roche Molecular Systems DQ-Alpha user guide
referenced as basis for LAPD protocol
Informal
Yamauchi's CV / curriculum vitae
consulted by witness on the stand; briefly reviewed by Scheck
Informal
Notes used by Yamauchi to recall first case dates (October/November 1993)
reviewed by Scheck at bench

Notable Exchanges (2)

Barry ScheckRockne HarmonLance A. Ito
Repeated hearsay objections over Matheson's statements to Yamauchi were sustained twice; the parties then conferred off the record and Scheck withdrew his objection after Harmon explained what the testimony would be, allowing the conversation to come in.
strategic
Rockne HarmonCollin Yamauchi
Harmon methodically establishes Yamauchi's glove-wearing and cross-contamination awareness from his pre-LAPD career at ICN Radiochemicals, preemptively addressing contamination arguments.
strategic

Light Moments (2)

Rockne Harmon
Harmon asks 'Do you wear gloves?' mid-sentence while Yamauchi is describing his ICN lab work — an abrupt pivot that reads as slightly awkward but clearly deliberate foreshadowing of contamination themes.
Collin Yamauchi
Yamauchi responds to Harmon's slip — 'Do you recall if anyone else was present when you had a conversation that you will be telling us about this afternoon' — with genuine confusion: 'This afternoon? What was that?' Harmon concedes 'Sorry. It was a bad question.'

Witness Demeanor

(Brief pause.) — while Yamauchi retrieves his CV
(Brief pause.) — while Scheck reviews Yamauchi's notes on first case dates
(Discussion held off the record between Deputy District Attorney and Defense counsel.)
(Discussion held off the record between Defense counsel.)
(No audible response.) — Yamauchi pauses before Scheck objects to hearsay

Objections

8 objections (4 sustained, 3 overruled)
Proceeding 6179 • 380 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 24, 1995 📄 Direct examination of Collin Y
MAY 24, 1995 KRT DvH TD